A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to CapturePR Newswire·2 days ago, 03:37 PMCNXU+1.53%
Conexeu Sciences to present at Nasdaq/LD Micro Summit SeriesPUBT·2 days ago, 12:32 PMCNXU+1.53%NDAQ+1.74%
Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectivesPUBT·Aug 18 at 12:55 PMCNXU+1.53%
Conexeu Sciences CMO presents on extracellular matrix role in tissue regeneration at Laser & Cosmetic Surgery symposiumPUBT·Aug 11 at 12:32 PMCNXU+1.53%
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Datarttnews·Jul 16 at 03:42 AMIOVA+1.10%MANE-1.24%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 15 at 05:05 PMCRDF0.00%SNTI+4.42%
11:01 ETThe GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.prnewswire·Jul 15 at 03:02 PMCNXU+1.53%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 7 at 05:05 PMCRNX0.00%AKTX-2.46%
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill ItPR Newswire·Jul 7 at 01:45 PMCNXU+1.53%
